ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,392,784, issued on Aug. 19, was assigned to Biogen MA Inc. (Cambridge, Mass.).
"Method of assessing risk of PML" was invented by Gary Lewis Bloomgren (Concord, Mass.), Carmen Bozic (Newton, Mass.), Sophia Lee (Waltham, Mass.), Amy Pace (Brookline, Mass.), Tatiana Plavina (North Reading, Mass.) and Meena Subramanyam (Stoneham, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to methods of assessing a patient' s risk of developing Progressive multifocal leukoencephalopathy (PML)."
The patent was filed on May 31, 2024, under Application No. 18/731,059.
*For further information, including images, charts and tables, please visit: ...